Morgan Stanley Shares Trail Rivals Amid UBS Deal Speculation and Lower Price Target
Morgan Stanley slipped on September 24 as reports discussed possible UBS merger considerations, then ended flat the next day while several large bank peers gained. Wells Fargo reduced its price target for Morgan Stanley, though analysts have continued to lift earnings estimates. Management has said it regularly reviews acquisitions that could expand capabilities or client relationships, but no deal with UBS has been confirmed.
Morgan Stanley slipped 1.04% on Sept. 24 as a Semafor report discussed UBS merger considerations. The bank’s name appeared in analysis, not sourced reporting. Wells Fargo then cut its target to $223 from $240. On Sept. 25, Morgan Stanley closed flat while Goldman Sachs, JPMorgan Chase, and Citigroup each rose more than 1%.
Since June 30, consensus next-twelve-month EPS estimates climbed about 8%, yet the stock fell 6.09%, trimming its forward P/E to roughly 15 times. Management has said it routinely reviews acquisitions and holds capital for deals that add capabilities or clients. No UBS agreement has been verified.
Speculation around a Morgan Stanley-UBS combination could affect investors, employees, and wealth-management clients through share-price swings and uncertainty. If talks ever advanced, consolidation might reshape competition in banking and asset management, potentially influencing fees, service options, and job stability. Swiss capital rules and cross-border oversight could also draw public scrutiny. For now, no confirmed deal means these effects remain speculative.